pharma · Advanced Systemic Mastocytosis · Systemic Mastocytosis
Blueprint Medicines
Blueprint Medicines (Netherlands) B.V.
Blueprint Medicines clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Cambridge, USA HQ
2011 Founded
741 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2011
- Employees
- 741
- Programs
- 8
- Drugs
- 9
- Patents
- 0
Blueprint Medicines projects
3 ClinicalTrials.gov programs sponsored by Blueprint Medicines.
Blueprint Medicines has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Blueprint Medicines have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.